Assessment of Clinical Drug‐Drug Interactions of Elagolix, a Gonadotropin‐Releasing Hormone Receptor Antagonist

Elagolix is an oral gonadotropin‐releasing hormone receptor antagonist indicated for the management of endometriosis‐associated pain and in combination with estradiol/norethindrone acetate indicated for the management of heavy menstrual bleeding associated with uterine leiomyomas (fibroids) in preme...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Pharmacol
Main Authors: Polepally, Akshanth R., Ng, Juki W., Salem, Ahmed Hamed, Dufek, Matthew B., Parikh, Apurvasena, Carter, David C., Kamradt, Kent, Mostafa, Nael M., Shebley, Mohamad
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2020
Assuntos:
Drug Interactions
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7689813/
https://ncbi.nlm.nih.gov/pubmed/33045114
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcph.1689
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares